Log In
Print this Print this

ThyGenX (ThyGen)

  Manage Alerts
Collapse Summary General Information
Company Interpace Diagnostics Group Inc.
DescriptionNext generation sequencing test to distinguish between benign and malignant genotypes in indeterminate thyroid nodules
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDiagnose thyroid cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today